1例转移性隐匿性乳腺癌的临床诊治

郝春芳 王淑玲 佟仲生

郝春芳, 王淑玲, 佟仲生. 1例转移性隐匿性乳腺癌的临床诊治[J]. 中国肿瘤临床, 2013, 40(1): 55-59. doi: 10.3969/j.issn.1000-8179.2013.01.014
引用本文: 郝春芳, 王淑玲, 佟仲生. 1例转移性隐匿性乳腺癌的临床诊治[J]. 中国肿瘤临床, 2013, 40(1): 55-59. doi: 10.3969/j.issn.1000-8179.2013.01.014
Chunfang HAO, Shuling WANG, Zhongsheng TONG. Metastatic occult breast cancer: diagnosis and treatment[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 40(1): 55-59. doi: 10.3969/j.issn.1000-8179.2013.01.014
Citation: Chunfang HAO, Shuling WANG, Zhongsheng TONG. Metastatic occult breast cancer: diagnosis and treatment[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 40(1): 55-59. doi: 10.3969/j.issn.1000-8179.2013.01.014

1例转移性隐匿性乳腺癌的临床诊治

doi: 10.3969/j.issn.1000-8179.2013.01.014
详细信息
    通讯作者:

    佟仲生  tonghang@medmail.com.cn

Metastatic occult breast cancer: diagnosis and treatment

More Information
  • 摘要: 隐匿性乳腺癌(occult breast cancer, OBC), 是较少见的特殊类型乳腺癌, 指经临床体检和影像学检查未发现乳房内包块而以腋窝淋巴结转移或其他远处转移为首发症状, 并经病理证实来源于乳腺组织的乳腺癌。对转移淋巴结进行组织病理学检查是OBC诊断的关键。对于钼靶和超声阴性的OBC, 增强核磁共振(MRI)检查在寻找原发灶方面有重要作用, 且有助于OBC的术前定位和指导手术方案。其手术治疗方法的选择尚有争议。现介绍1例晚期转移性OBC, 经多学科联合诊治、予以个体化综合治疗的成功经验, 为OBC的诊治提供更多思路, 强调多学科协作诊疗模式。

     

  • 图  1  2012-04-23左锁上淋巴结切检病理切片及免疫组化

    A:HE;B:EMA(+);C:ER(85%);D:PR(80%);E:CA-153(+);F:GCDFP-15(+);G:MG(+);H:CK7(+)

    Figure  1.  2012-04-23 Left supraclavicular lymph node pathological and immunohistochemical examination

    图  2  2012-04-23乳腺钼靶

    Figure  2.  Mammography 2012-04-23

    图  3  2012-05-07乳腺MRI

    Figure  3.  Breast MRI 2012-05-07

    图  4  2012-05-07乳腺第二眼超声

    Figure  4.  Breast second-look ultrasound 2012-05-07

    图  5  乳腺MRI检诊OBC推荐程序

    Figure  5.  Recommended procedures of breast MRI detection and diagnosis of OBC

    表  1  隐匿性乳腺癌患者治疗经过

    Table  1.   Treatment of the patient with occult breast cancer

  • [1] de Bresser J, de Vos B, van der Ent F, et al. Breast MRI in clinicallyand mammographically occult breast cancer presenting with an axil lary metastasis: a systematic review[J]. Eur J Surg Oncol, 2010, 36(2): 114-119. doi: 10.1016/j.ejso.2009.09.007
    [2] 李小康, 徐熠琳, 刘佩芳, 等. 乳腺MRI在X线检查乳腺阴性腋淋巴结转移癌阳性患者中的应用价值[J]. 中华放射学杂志, 2011, 45(4): 348-352. doi: 10.3760/cma.j.issn.1005-1201.2011.04.006
    [3] Lu H, Xu YL, Zhang SP, et al. Breast magnetic resonance imaging inpatients with occult breast carcinoma: evaluation on feasibility andcorrelation with histopathological findings[J]. Chin Med J(Engl), 2011, 124(12): 1790-1795.
    [4] Candelaria R, Fornage BD. Second-look US examination ofMR-detected breast lesions[J]. J Clin Ultrasound, 2011, 39(3): 115-121. doi: 10.1002/jcu.20784
    [5] Walter C, Scheidhauer K, Scharl A, et al. Clinical and diagnostic valueof preoperative MR mammography and FDG-PET in suspiciousbreast lesions s[J]. Eur Radiol, 2003, 13(7): 1651-1656. doi: 10.1007/s00330-002-1816-1
    [6] Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expres sion in epithelial neoplasms: a survey of 435 cases[J]. Mod Pathol, 2000, 13(9): 962-972. doi: 10.1038/modpathol.3880175
    [7] 牛昀, 傅西林, 牛瑞芳, 等. 抗人乳腺癌单抗M4G3在隐性乳腺癌诊断中的应用[J]. 中华实验外科杂志, 2003, 20(7): 654-657. doi: 10.3760/j.issn:1001-9030.2003.07.031
    [8] Merson M, Andreola S, Galimberti V, et al. Breast carcinoma pre senting as axillary meatastases without evidence of a primary tumor[J]. Cancer, 1992, 70(2): 504-508. doi: 10.1002/1097-0142(19920715)70:2<504::AID-CNCR2820700221>3.0.CO;2-T
    [9] 刘鹏, 苏亦男, 刘艳, 等. 隐性乳腺癌的诊治(附68例报告)[J]. 中国肿瘤临床, 2007, 34(7): 391-393. doi: 10.3969/j.issn.1000-8179.2007.07.009
    [10] Ruiterkamp J, Ernst MF, van de Poll-Franse LV, et al. Surgical re section of the primary tumour is associated with improved survivalin patients with distant metastatic breast cancer at diagnosis[J]. EurJ Surg Oncol, 2009, 35(11): 1146-1151. doi: 10.1016/j.ejso.2009.03.012
  • 加载中
图(5) / 表(1)
计量
  • 文章访问数:  34
  • HTML全文浏览量:  2
  • PDF下载量:  0
  • 被引次数: 0
出版历程
  • 收稿日期:  2012-12-31
  • 修回日期:  2013-01-03

目录

    /

    返回文章
    返回